login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
APOLLOMICS INC (APLM) Stock News
NASDAQ:APLM - Nasdaq -
KYG0411D1236
-
Common Stock
- Currency: USD
5.87
+0.05 (+0.86%)
Summary
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
APLM Latest News, Press Relases and Analysis
All
Press Releases
9 days ago - By: Benzinga
- Mentions:
CYH
WST
SRPT
HCTI
...
12 Health Care Stocks Moving In Thursday's Intraday Session
24 days ago - By: Benzinga
- Mentions:
WINT
VRNA
MBIO
KZIA
...
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
4 months ago - By: Apollomics Inc.
Apollomics Reports Full Year 2024 Financial Results and Highlights Clinical Updates and Business Progress
4 months ago - By: Apollomics Inc.
Apollomics Reports Full Year 2024 Financial Results and Highlights Clinical Updates and Business Progress
4 months ago - By: Apollomics Inc.
Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib
4 months ago - By: Apollomics Inc.
Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib
7 months ago - By: Apollomics Inc.
Apollomics 公布 Uproleselan 在中國治療復發或難治性急性髓系白血病患者的第 3 期銜接性試驗的主要結果
7 months ago - By: Apollomics Inc.
Apollomics 公布在中国对复发或难治性急性髓系白血病患者进行的 Uproleselan III 期桥接试验主要结果
7 months ago - By: Apollomics Inc.
Apollomics Announces Top-line Results for Phase 3 Bridging Trial of Uproleselan in China in Patients with Relapsed or Refractory Acute Myeloid Leukemia
8 months ago - By: Apollomics Inc.
Apollomics Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
8 months ago - By: Apollomics Inc.
Apollomics Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
8 months ago - By: Apollomics Inc.
Apollomics’ Announces Shareholder Approval and Effective Date for 1-for-100 Reverse Share Split
8 months ago - By: Apollomics Inc.
Apollomics’ Announces Shareholder Approval and Effective Date for 1-for-100 Reverse Share Split
11 months ago - By: Apollomics Inc.
Apollomics Presents Vebreltinib Data in Patients with Non-Small Cell Lung Cancer with METex14 Skipping Mutations at European Society for Medical Oncology (ESMO) Congress 2024
a year ago - By: Apollomics Inc.
Apollomics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
a year ago - By: Apollomics Inc.
Apollomics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
a year ago - By: Apollomics Inc.
Apollomics Reports First Half 2024 Financial Results and Highlights Vebreltinib Clinical Progress
a year ago - By: Apollomics Inc.
Apollomics Reports First Half 2024 Financial Results and Highlights Vebreltinib Clinical Progress
a year ago - By: Apollomics Inc.
Apollomics Announces Positive Preliminary Data of Vebreltinib in Patients with Non-CNS MET Fusion Solid Tumors from its Phase 2 SPARTA Trial
a year ago - By: Apollomics Inc.
Apollomics Announces Positive Preliminary Data of Vebreltinib in Patients with Non-CNS MET Fusion Solid Tumors from its Phase 2 SPARTA Trial
a year ago - By: Apollomics Inc.
Apollomics to Present at the Canaccord Genuity 44th Annual Growth Conference
a year ago - By: Apollomics Inc.
Apollomics to Present at the Canaccord Genuity 44th Annual Growth Conference
a year ago - By: InvestorPlace
- Mentions:
CHUY
ONCO
BNOX
DSY
...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Please enable JavaScript to continue using this application.